Shicheng Li - PharmaResources Financial Supervisor
| 301230 Stock | 27.35 0.35 1.30% |
Executive
Shicheng Li is Financial Supervisor of PharmaResources Co Ltd
| Age | 47 |
| Address | Building 12, Shanghai, China, 201201 |
| Web | https://www.pharmaresources.cn |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jie Huang | China Mobile Limited | N/A | |
| Jiajin Lyu | Industrial Bank Co | 56 | |
| Benjamin Deng | Ping An Insurance | 55 | |
| Jianhua Song | Industrial and Commercial | 59 | |
| Jianguang Wu | Bank of China | 58 | |
| Xiaotao Guo | Ping An Insurance | 51 | |
| Fenglin Tian | Industrial and Commercial | 57 | |
| Li Li | China Merchants Bank | N/A | |
| Sau Ng | Agricultural Bank of | N/A | |
| Tang Jiacai | Industrial Bank Co | N/A | |
| Rujun Shen | Industrial and Commercial | 60 | |
| Taifeng Xie | Industrial and Commercial | 52 | |
| Bresson Xu | Industrial and Commercial | N/A | |
| Jianjiang Li | China Construction Bank | 51 | |
| Zhao Cai | Bank of China | 51 | |
| Li Huang | Industrial and Commercial | 60 | |
| Chengwen Zhuo | Bank of China | 54 | |
| Jicheng Qiu | China Construction Bank | 52 | |
| Panshi Jin | China Construction Bank | 59 | |
| Lei Zhang | PetroChina Co Ltd | N/A | |
| FCS FCIS | China Construction Bank | 47 | |
Management Performance
| Return On Equity | 0.0064 | ||||
| Return On Asset | -0.0102 |
PharmaResources Leadership Team
Elected by the shareholders, the PharmaResources' board of directors comprises two types of representatives: PharmaResources inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaResources. The board's role is to monitor PharmaResources' management team and ensure that shareholders' interests are well served. PharmaResources' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaResources' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shengli Jiang, Deputy Director | ||
| Haifeng Li, Deputy Manager | ||
| Shicheng Li, Financial Supervisor | ||
| Rongchang An, Founder Director | ||
| Weicai Zhen, Deputy Manager | ||
| Hongjian Zhang, CoFounder Officer | ||
| Ping Chen, GM, CoFounder |
PharmaResources Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaResources a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0064 | ||||
| Return On Asset | -0.0102 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 3.59 B | ||||
| Shares Outstanding | 139.59 M | ||||
| Shares Owned By Insiders | 53.20 % | ||||
| Shares Owned By Institutions | 15.31 % | ||||
| Price To Book | 3.61 X | ||||
| Price To Sales | 7.43 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in PharmaResources Stock
PharmaResources financial ratios help investors to determine whether PharmaResources Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmaResources with respect to the benefits of owning PharmaResources security.